Heart valve disease presenting in adults: investigation and management

The consultation closes at 5pm on 29 April 2021

How to comment

1. Register your organisation or comment as an individual

If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.

2. Read the consultation documents

Documents to comment on:

• Draft guideline– just the recommendations
• Evidence reviews:
• Evidence review A – Symptoms or signs indicating referral for echocardiography or specialist assessment
• Evidence review B – Referral to a specialist following echocardiography
• Evidence review C – Pharmacological management of heart valve disease
• Evidence review D – Echocardiography to determine the need for intervention
• Evidence review E – Stress testing and stress echocardiography to determine the need for intervention
• Evidence review F– Cardiac MRI and cardiac CT to determine the need for intervention
• Evidence review G – Monitoring where there is no current need for intervention
• Evidence review H – Interventions
• Evidence review I– Repeat interventions
• Evidence review J– Antithrombotic therapy
• Evidence review K – Monitoring after an intervention
• Evidence review L– Information and advice
• Supporting documentation - Acknowledgements
• Supporting documentation - Methods
• Supporting documentation - Algorithm
• Economic model reports -  TAVI and MitraClip
• Economic models

If you want to review the economic models, please see 5. Economic models below and fill in the confidentiality form.

Other information about the consultation

• Equality impact assessment
• Committee member list and Register of interests
• Developing NICE guidelines: how to get involved

3. Add your comments

• You must use this comments form.
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges

Developing NICE guidelines: how to get involved suggests some other areas to comment on.

4. Email the form to us

Email: HVD@nice.org.uk

Deadline: 5pm on 29 April 2021

5. Economic model

The developer has produced economic models to support the guideline on heart valve disease presenting in adults: investigation and management  To receive an executable version of the models, please submit a request to HVD@nice.org.uk with a signed copy of the confidentiality acknowledgement and undertaking form.

We will then send you a link to an executable version of the economic model by email. The deadline for returning your comments is the same as for the guideline consultation: 5pm on 29 April 2021.